Co-Authors
This is a "connection" page, showing publications co-authored by Airu Zhu and Jincun Zhao.
Connection Strength
2.644
-
Potent prophylactic and therapeutic efficacy of recombinant human ACE2-Fc against SARS-CoV-2 infection in vivo. Cell Discov. 2021 Aug 12; 7(1):65.
Score: 0.240
-
Mapping and role of T cell response in SARS-CoV-2-infected mice. J Exp Med. 2021 04 05; 218(4).
Score: 0.235
-
Intra-host variation and evolutionary dynamics of SARS-CoV-2 populations in COVID-19 patients. Genome Med. 2021 02 22; 13(1):30.
Score: 0.233
-
T-cell responses to MERS coronavirus infection in people with occupational exposure to dromedary camels in Nigeria: an observational cohort study. Lancet Infect Dis. 2021 03; 21(3):385-395.
Score: 0.227
-
Kinetics of viral load and antibody response in relation to COVID-19 severity. J Clin Invest. 2020 10 01; 130(10):5235-5244.
Score: 0.226
-
Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment. Cell. 2020 08 06; 182(3):734-743.e5.
Score: 0.222
-
Complete Genome Sequences of Five Human Coronavirus NL63 Strains Causing Respiratory Illness in Hospitalized Children in China. Microbiol Resour Announc. 2020 Feb 20; 9(8).
Score: 0.217
-
Discovery of a subgenotype of human coronavirus NL63 associated with severe lower respiratory tract infection in China, 2018. Emerg Microbes Infect. 2020; 9(1):246-255.
Score: 0.216
-
Current understanding of middle east respiratory syndrome coronavirus infection in human and animal models. J Thorac Dis. 2018 Jul; 10(Suppl 19):S2260-S2271.
Score: 0.194
-
A Confirmed Case of SARS-CoV-2 Pneumonia With Negative Routine Reverse Transcriptase-Polymerase Chain Reaction and Virus Variation in Guangzhou, China. Clin Infect Dis. 2021 07 15; 73(2):e426-e433.
Score: 0.060
-
Longitudinal virological changes and underlying pathogenesis in hospitalized COVID-19 patients in Guangzhou, China. Sci China Life Sci. 2021 12; 64(12):2129-2143.
Score: 0.059
-
Multi-platform omics analysis reveals molecular signature for COVID-19 pathogenesis, prognosis and drug target discovery. Signal Transduct Target Ther. 2021 04 15; 6(1):155.
Score: 0.059
-
Analysis of pathological changes in the epithelium in COVID-19 patient airways. ERJ Open Res. 2021 Apr; 7(2).
Score: 0.059
-
Population Bottlenecks and Intra-host Evolution During Human-to-Human Transmission of SARS-CoV-2. Front Med (Lausanne). 2021; 8:585358.
Score: 0.058
-
The proteomic characteristics of airway mucus from critical ill COVID-19 patients. Life Sci. 2021 Mar 15; 269:119046.
Score: 0.058
-
Narrative review of the novel coronavirus SARS-CoV-2: update on genomic characteristics, transmissions and animal model. J Thorac Dis. 2020 Dec; 12(12):7454-7466.
Score: 0.057
-
Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient. Emerg Microbes Infect. 2020 Dec; 9(1):991-993.
Score: 0.057
-
Elevated MUC1 and MUC5AC mucin protein levels in airway mucus of critical ill COVID-19 patients. J Med Virol. 2021 02; 93(2):582-584.
Score: 0.056
-
Single-cell analysis reveals bronchoalveolar epithelial dysfunction in COVID-19 patients. Protein Cell. 2020 09; 11(9):680-687.
Score: 0.056
-
Human post-infection serological response to the spike and nucleocapsid proteins of SARS-CoV-2. Influenza Other Respir Viruses. 2021 01; 15(1):7-12.
Score: 0.056